Skip to main content

Notices of approved actions

The table below shows Pending policy notices with detailed Item name, board action date, and target implementation date

Item Board Action Target Implementation
Barriers Related to the Evaluation and Follow up of International Living Donors (PDF) 06/2025 07/01/2025

Updates to National Liver Review Board Guidance and Further Alignment with LI-RADS (PDF)

  • Guidance Documents
  • HCC Policy and Guidance Documentation
06/2025

  • 07/01/2025
  • 09/2026
Establish Member System Access, Security Framework, and Incident Management and Reporting Requirement (PDF) 06/2023 07/2025
  • Information security audits
07/2025
Clarify Requirements for Reporting a Potential Disease Transmission (PDF) 06/2025 08/01/2025
Standardize the Patient Safety Contact and Reduce Duplicate Reporting (PDF)
  • Updates to Patient Safety Contact Requirements
06/2024 08/2025
Monitor Ongoing eGFR Modification Policy Requirements (PDF) 06/2025 09/10/2025
Promote Efficiency of Lung Allocation (PDF) 06/2024 09/2025
Update Post-Transplant Histocompatibility Data (PDF) 06/2024 09/2025
Promote Efficiency of Lung Donor Testing (PDF) 12/2024 09/2025

Update Data Collection for Lung Mortality Models (PDF)

  • Updates to the Data System

12/2022

  • 09/2025 pending OMB approval

Align OPTN KPD Blood Type Matching Policy and Establish Donor Re-Evaluation Requirements (PDF) 06/2023 09/2025 pending OMB approval
Amend Adult Heart Status 2 Mechanical Device Requirements (PDF) 12/2023 09/2025 pending OMB approval
Deceased Donor Support Therapy Data Collection (PDF) 12/2023 09/2025 pending OMB approval
Enhancements to OPTN Donor Data and Matching System Clinical Data Collection (PDF) 12/2022 09/2025 pending OMB approval
Improve Deceased Donor Evaluation for Endemic Diseases (PDF) 06/2023 09/2025 pending OMB approval
Escalation of Status for Time on Left Ventricular Assist Device (PDF) 06/2025 09/2026
Modify Lung Donor Data Collection (PDF) 06/2025 12/2026
Update Histocompatibility Membership Requirements (PDF) 12/2024 pending OMB approval